[{"start_date": "2025-07-01", "end_date": "2025-09-30", "filing_date": "2025-11-06", "acceptance_datetime": "2025-11-06T13:23:52Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2025", "cik": "0001691082", "sic": "2834", "tickers": ["LBRX"], "company_name": "LB PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-25-268174", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-25-268174/files/lbrx-20250930_htm.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": -3609000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -3609000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -3609000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"basic_earnings_per_share": {"value": -0.61, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "nonoperating_income_loss": {"value": 1690000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "research_and_development": {"value": 2419000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -3556000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_earnings_per_share": {"value": -0.61, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_before_tax": {"value": -3556000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": -3556000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 5246000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": -3556000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_average_shares": {"value": 5806862.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "diluted_average_shares": {"value": 5806862.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "other_operating_expenses": {"value": 2827000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -3556000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_noncurrent_assets": {"value": 2710000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 6647000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 310221000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 320746000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 3878000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 316401000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 10525000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 320746000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 4345000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "cash": {"value": 314500000.0, "unit": "USD", "label": "Cash", "order": 210}, "fixed_assets": {"value": 1635000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "accounts_payable": {"value": 2590000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_assets": {"value": 1901000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity": {"value": 310221000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_current_liabilities": {"value": 4057000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}}}, {"start_date": "2025-04-01", "end_date": "2025-07-01", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2025", "cik": "0001691082", "sic": "2834", "tickers": ["LBRX"], "company_name": "LB PHARMACEUTICALS INC", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -4870000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -4870000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_liabilities": {"value": 103873000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": -103873000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": 103873000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": -103873000.0, "unit": "USD", "label": "Equity", "order": 1400}}, "income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -4870000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -4870000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -4870000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": -4870000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -4870000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}}}, {"start_date": "2025-01-01", "end_date": "2025-03-31", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2025", "cik": "0001691082", "sic": "2834", "tickers": ["LBRX"], "company_name": "LB PHARMACEUTICALS INC", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -5307000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -5307000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -5307000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -5307000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -5307000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -5307000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_before_tax": {"value": -5307000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_liabilities": {"value": 99338000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": -99338000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 99338000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": -99338000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}}}]